OUR LEGACY - AND FUTURE -
IN AMERICAN MANUFACTURING

When you think of a pharmaceutical company, you may picture scientists and researchers in labs creating new or better medications to help tackle diseases. But there’s more.

Those scientists and researchers are only one part of the equation. After all, medication is of no use if it does not get to the people who need it.

Merck has a dedicated team of people who make these medicines, as well as package and distribute them to the people who need them. These employees, located all over the country, make our break-through inventions a reality.

Our manufacturing facilities, suppliers and partners comprise a global manufacturing network that is committed to delivering medicines and vaccines to customers and patients.

Merck is part of the fabric of the communities where our 25,000 U.S. employees work and live — in all 50 states across the U.S. We have more manufacturing employees in the U.S. than we have in any other country with full-time employees in highly skilled jobs that pay well and generate growth for the U.S. economy.

$3
BILLION

Nearly $3 billion in manufacturing assets are currently deployed in the U.S. supporting our global supply of products.

$50
BILLION

Since 2010, Merck has invested more than $50 billion into R&D, most in the U.S., creating jobs and stimulating local economies.

MADE
IN U.S.

Bulk materials for all of Merck’s FDA-approved vaccines for people in the U.S. are made in the U.S.

MADE
LOCAL

Global manufacturing has its headquarters in New Jersey, and we have grown our West Point, Pennsylvania plant - acquired in the merger with Sharp and Dohme - into the largest in our network.

$1
BILLION

Over the past decade, Merck has invested more than $1 billion in our manufacturing facilities in the U.S.

$1.5
BILLION

Last year, Merck paid about $1.5 billion in total U.S. Employer and Employee taxes (including Federal State, local, and unemployment tax) with the Employer-only taxes equaling approximately $250 million.

Merck has been manufacturing for more than 125 years. Our current “Manufacturing the Future” strategy focuses on ensuring compliance, becoming a world-class supplier and improving cost-efficiency. Today, as in the past, Merck is dedicated to compliance, safety, and supply chain excellence, as well as “safety first, quality always.”

STATE-SPECIFIC INFORMATION:

New Jersey

NEW JERSEY
+6,000 Employees

Home of our global headquarters since 1992. Merck has more than 6,000 employees in New Jersey, many of them researchers.

Virginia

VIRGINIA
+700 Employees

Merck employs more than 700 employees in Virginia, most at our manufacturing plant in Elkton, in Rockingham County.

Pennsylvania

PENNSYLVANIA
+13,000 Employees

Merck employs more than 13,000 people in Pennsylvania, with 3,000 in manufacturing and 3,000 in research.

  • Merck’s manufacturing plant in West Point is the largest manufacturing site in our company’s network
  • Merck is the largest private sector employer in Montgomery County and 14th-largest private sector employer in the state
North Carolina

NORTH CAROLINA
+1,600 Employees

Merck employs more than 1,600 employees in North Carolina, most at our manufacturing plants in Durham and Wilson counties.

USA

DELAWARE + KANSAS + LOUISIANA + NEBRASKA
+800 Employees

Merck employs more than 800 people in Animal Health manufacturing plants.